Long-acting injectable cabotegravir for HIV prevention safe in pregnancy, suggests study Dr. Kamal Kant Kohli31 July 2024 8:00 PM ISTLong-acting injectable cabotegravir (CAB-LA) was safe and well tolerated as HIV pre-exposure prophylaxis (PrEP) before and during pregnancy in the...
GSK HIV prevention drug gets European Commission authorisation Ruchika Sharma19 Sept 2023 2:30 PM ISTLondon: GSK plc has announced that ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders,...
Cipla, Aurobindo, Viatris in licensing pact with MPP to produce generic versions of ViiV Healthcare HIV drug Ruchika Sharma31 March 2023 3:09 PM ISTAurobindo and Viatris will manufacture in India; Cipla will manufacture in India and has plans to manufacture in South Africa as well.
ViiV Healthcare Cabotegravir long-acting injectable for HIV prevention gets EMA validation Ruchika Sharma30 Oct 2022 11:45 AM ISTCabotegravir long-acting for PrEP is an integrase strand transfer inhibitor (INSTI).
GSK strikes deal to allow cheap generic versions of HIV preventive medicine Ruchika Sharma30 July 2022 12:26 PM ISTMPP offers generic manufacturers the opportunity to apply to make copycat versions of the injected drug, cabotegravir, for the 90 countries that...
